Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.
Clin Exp Immunol. 2014 Jul;177(1):47-63. doi: 10.1111/cei.12339.
Fluorochrome-conjugated peptide-major histocompatibility complex (pMHC) multimers are widely used for flow cytometric visualization of antigen-specific T cells. The most common multimers, streptavidin-biotin-based 'tetramers', can be manufactured readily in the laboratory. Unfortunately, there are large differences between the threshold of T cell receptor (TCR) affinity required to capture pMHC tetramers from solution and that which is required for T cell activation. This disparity means that tetramers sometimes fail to stain antigen-specific T cells within a sample, an issue that is particularly problematic when staining tumour-specific, autoimmune or MHC class II-restricted T cells, which often display TCRs of low affinity for pMHC. Here, we compared optimized staining with tetramers and dextramers (dextran-based multimers), with the latter carrying greater numbers of both pMHC and fluorochrome per molecule. Most notably, we find that: (i) dextramers stain more brightly than tetramers; (ii) dextramers outperform tetramers when TCR-pMHC affinity is low; (iii) dextramers outperform tetramers with pMHC class II reagents where there is an absence of co-receptor stabilization; and (iv) dextramer sensitivity is enhanced further by specific protein kinase inhibition. Dextramers are compatible with current state-of-the-art flow cytometry platforms and will probably find particular utility in the fields of autoimmunity and cancer immunology.
荧光标记肽-主要组织相容性复合体(pMHC)多聚体被广泛用于流式细胞术检测抗原特异性 T 细胞。最常见的多聚体,基于链霉亲和素-生物素的“四聚体”,可以在实验室中很容易地制造。不幸的是,从溶液中捕获 pMHC 四聚体所需的 T 细胞受体(TCR)亲和力的阈值与激活 T 细胞所需的阈值之间存在很大差异。这种差异意味着四聚体有时不能在样品中染色抗原特异性 T 细胞,当染色肿瘤特异性、自身免疫或 MHC Ⅱ类限制的 T 细胞时,这个问题尤其成问题,这些 T 细胞通常显示对 pMHC 的 TCR 亲和力较低。在这里,我们比较了优化的四聚体和葡聚糖多聚体(葡聚糖基多聚体)染色,后者每个分子携带更多的 pMHC 和荧光染料。最值得注意的是,我们发现:(i)葡聚糖多聚体比四聚体染色更亮;(ii)当 TCR-pMHC 亲和力较低时,葡聚糖多聚体比四聚体表现更好;(iii)在缺乏共受体稳定化的情况下,葡聚糖多聚体比 pMHC Ⅱ类试剂的四聚体表现更好;(iv)通过特定的蛋白激酶抑制进一步增强了葡聚糖多聚体的敏感性。葡聚糖多聚体与当前最先进的流式细胞术平台兼容,可能会在自身免疫和癌症免疫学领域特别有用。